- Risks associated with manufacturing and supplying a high-quality product
- Risks of long-term adverse reactions not detected, off-label use or questionable benefits
- Risks of being limited by the technological platform to develop certain treatments
- Risks related to the implementation of certain access-to-medicines strategies
- Risks of inadequate pricing in relation to product benefits
- Risks of limiting the financial value created by the financial risks associated with pharmaceutical development activities
- Risks related to technological limitations and intellectual property management
- Risks associated with insufficient value creation and sharing
- Risks linked to the difficulty of attracting and retaining talented employees
- Risks linked to deteriorating working conditions
Medincell S.A.
Greenhouse gas emissions & sustainability report data
In its 2023-04 to 2024-03 reporting, Medincell S.A. disclosed greenhouse gas emissions of 5.3K tCO2e/year. By scope: Scope 1: 0.776 tCO2e/year; Scope 2: 40.82 tCO2e/year; Scope 3: 5.3K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
5.3K tCO2e/year
2023-04 to 2024-03
Renewable Energy
2.55%
of total energy
Water Usage
819 m3/year
2023-04 to 2024-03
Waste
19.095 tons/year
2023-04 to 2024-03
Energy Use
690.7K kWh/year
2023-04 to 2024-03
📊 Emissions by Scope (2023-04 to 2024-03)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 0.776 tCO2e/year |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 40.82 tCO2e/year |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 5.3K tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023-04 to 2024-03 | 5.3K tCO2e/year |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Reduced water consumption by 13%
- Upgraded electricity supply contract to a 100% renewable energy mix (post-closing)
- Overall volume of waste decreased slightly (15%)
- Use of the electric vehicle avoided the generation of 0.941 t of CO2e for a total of 3,113 km of travel
- Klaxit application lists 15,000 km saved by carpooling and the corresponding carbon footprint of 1.694 t CO2e
🎯 Climate & Sustainability Targets
🔜 Short-term
- Reduce TF3 to 70
📅 Medium-term
- Stabilize the energy intensity of our offices at 40 kWh/m2/year for the HVAC component and 116 kWh/m2/year for the USE component
- Stabilize the energy intensity of our laboratory
🔭 Long-term
- Reduce the cumulative annual accident and injury frequency rate (TF3) to less than 20
- Reduce waste and laboratory effluent intensity by 5%
🌱 ESG Focus Areas
Good Health & Well-beingGender EqualityPartnerships for the GoalsClean Water & SanitationProduct Quality & SafetyTechnological InnovationAccess to MedicineValue Creation aligned with SDGsRetain and Develop TalentsEmployee Health and SafetyDiversity, Inclusion & Gender EqualityCarbon FootprintResources ManagementPollution & BiodiversityBusiness EthicsGood Governance and Legal Compliance